Virtual Charcot-Marie-Tooth Examination Score
A Validated Virtual Evaluation for People With Charcot-Marie-Tooth Disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 5, 2022
- Accepted June 27, 2022
- First Published August 31, 2022.
Article Versions
- Previous version (August 31, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Valeria Prada, PhD, PT,
- Matilde Laurà, MD, PhD,
- Riccardo Zuccarino, MD, PhD,
- Mary M. Reilly, MD and
- Michael E. Shy, MD
- Valeria Prada, PhD, PT,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Matilde Laurà, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Riccardo Zuccarino, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Mary M. Reilly, MD and
Commercial<br><br>1. Eidos steering committee
NONE
None
(1) Neuromuscular Disorders, Editorial Board (current)<br>(2) European Journal of neurology, editorial board (current)
NONE
NONE
NONE
(1)Commercial entity:<br>Occasional consultancy for Alynam,<br>Inflectis, IONIS and Akcea
1. Commercial Alnylam Symposium EAN 2021
NONE
NONE
NONE
NIH grantS U54NS065712, 1UOINS109403-01, R21TR003034<br>MRC grant MR/S005021/1
•MDA grant (MDA510281) Muscle MRI in Charcot Marie <br>Tooth disease (PI) 2017-2021<br>CMTA grants for CMT1B,2A and 1X
None
NONE
NONE
NONE
NONE
NONE
NONE
- Michael E. Shy, MD
(1) Charcot Marie Tooth Association-Non Profit<br>(2) Muscular Dystrophy Association (MDA)-Non Profit
Applied Therapeutics Commercial entity for developing a <br>treatment trial for a peripheral neuropathy. Not relevant to <br>the current study
None
Neuromuscular Disorders, Editorial Board<br>Muscle and Nerve, Editorial Board
NONE
NONE
NONE
(1) Alnylam Pharmaceuticals - Consultant<br>(2) Mitochondria in Motion-Consultant<br>(3) Inflectis BioSci - Consultant<br>(4) Neurogene - Consultant<br>(5) Applied Therapeutics - (Consultant)
NONE
NONE
NONE
NONE
NINDS/Office of Rare Disease/NCATS
NONE
(1) Muscular Dystrophy Association;<br>(2) Charcot Marie Tooth Association
NONE
NONE
NONE
NONE
NONE
NONE
- From the University of Iowa (V.P., M.E.S.), Carver College of Medicine, Iowa City, IA; FISM (V.P.), Fondazione italiana Sclerosi Multipla, Genova, Italy; Department of Neuromuscular Diseases (M.L., M.M.R.), UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, United Kingdom; and Centro Clinico NeMO Trento (R.Z.), Fondazione Serena ONLUS, Pergine Valsugana (Trento), Italy.
- Correspondence
Dr. Prada valeria.prada{at}gmail.com
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.